R&D
An R&D cloud platform which supports scientists to share and access progress with the development of biopharmaceutical therapeutics has raised $35 million in investment capital.
The funding was led by ETF and an investor consortium from across AI, science and analytics.
AI has been the buzz word this year across multiple industries and now top government officials are starting to take notice.